首页 正文

Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia

{{output}}
Measurable (minimal) residual disease (MRD) status in acute lymphoblastic leukemia (ALL) has largely superseded the importance of traditional risk factors for ALL, such as baseline white blood cell count, cytogenetics, and immunophenotype, and has emerged as t... ...